The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease
- PMID: 11801257
- DOI: 10.1016/s0014-5793(01)03269-0
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease
Abstract
The concentration of neuromelanin (NM) in substantia nigra pars compacta (SNPC) has been measured in male and female normal subjects at different ages in the range 1-97 years old and in SNPC of parkinsonian patients. A very similar age trend of NM concentration was found in both sexes. In the first year of life NM was not detectable, between 10 and 20 years the NM levels were 0.3-0.8 microg/mg of SNPC, between 20 and 50 years were 0.8-2.3 microg/mg SNPC and between 50 and 90 were 2.3-3.7 microg/mg of SNPC. In parkinsonian subjects, the NM levels were 1.2-1.5 microg/mg of SNPC, which is less than 50% with respect to the age-matched controls. These data demonstrate a continuous NM accumulation in SNPC neurons during aging, the presence of large amounts of NM in SNPC and severe depletion of NM in Parkinson's disease.
Similar articles
-
Life span pigmentation changes of the substantia nigra detected by neuromelanin-sensitive MRI.Mov Disord. 2018 Nov;33(11):1792-1799. doi: 10.1002/mds.27502. Epub 2018 Nov 13. Mov Disord. 2018. PMID: 30423212 Free PMC article.
-
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.Neuroreport. 2006 Jul 31;17(11):1215-8. doi: 10.1097/01.wnr.0000227984.84927.a7. Neuroreport. 2006. PMID: 16837857
-
Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta.Mov Disord. 2017 Mar;32(3):441-449. doi: 10.1002/mds.26883. Epub 2016 Dec 22. Mov Disord. 2017. PMID: 28004859
-
The enigma of neuromelanin in Parkinson's disease substantia nigra.J Neural Transm Suppl. 1994;43:113-22. J Neural Transm Suppl. 1994. PMID: 7884393 Review.
-
New face of neuromelanin.J Neural Transm Suppl. 2006;(70):119-23. doi: 10.1007/978-3-211-45295-0_19. J Neural Transm Suppl. 2006. PMID: 17017518 Review.
Cited by
-
Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges.Int J Mol Sci. 2024 Feb 7;25(4):2009. doi: 10.3390/ijms25042009. Int J Mol Sci. 2024. PMID: 38396687 Free PMC article. Review.
-
Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson's disease.NPJ Parkinsons Dis. 2024 Feb 9;10(1):34. doi: 10.1038/s41531-024-00641-1. NPJ Parkinsons Dis. 2024. PMID: 38336768 Free PMC article.
-
Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.J Neural Transm (Vienna). 2024 Mar;131(3):213-228. doi: 10.1007/s00702-023-02718-2. Epub 2024 Jan 18. J Neural Transm (Vienna). 2024. PMID: 38238531
-
Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson's disease.Sci Adv. 2024 Jan 12;10(2):eadi8287. doi: 10.1126/sciadv.adi8287. Epub 2024 Jan 10. Sci Adv. 2024. PMID: 38198537 Free PMC article.
-
Melanin-The Éminence Grise of Melanoma and Parkinson's Disease Development.Cancers (Basel). 2023 Nov 23;15(23):5541. doi: 10.3390/cancers15235541. Cancers (Basel). 2023. PMID: 38067245 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
